|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities - available for sale | ||||||||||||||||||||
| Securities - equity investments | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $11,460 and $10,896 at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $11,172 and $12,381 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Cash surrender value of life insurance | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Interest receivable and other assets | ||||||||||||||||||||
| Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, no par value; 50,000,000 shares authorized, 8,413,458 and 8,388,221 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
Loading...
